purchase customization

1 Lifestyle Drugs Market Overview
1.1 Product Overview and Scope of Lifestyle Drugs
1.2 Lifestyle Drugs Segment by Therapeutic Type
1.2.1 Global Lifestyle Drugs Sales Growth Rate Comparison by Therapeutic Type (2023-2030)
1.2.2 Depression
1.2.3 Dermatology
1.2.4 Sexual Dysfunction
1.2.5 Obesity
1.2.6 Others
1.3 Lifestyle Drugs Segment by Sales Channel
1.3.1 Global Lifestyle Drugs Sales Comparison by Sales Channel: (2023-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Lifestyle Drugs Market Size Estimates and Forecasts
1.4.1 Global Lifestyle Drugs Revenue 2018-2030
1.4.2 Global Lifestyle Drugs Sales 2018-2030
1.4.3 Lifestyle Drugs Market Size by Region: 2018 Versus 2022 Versus 2030
2 Lifestyle Drugs Market Competition by Manufacturers
2.1 Global Lifestyle Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Lifestyle Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Lifestyle Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Lifestyle Drugs Manufacturing Sites, Area Served, Product Type
2.5 Lifestyle Drugs Market Competitive Situation and Trends
2.5.1 Lifestyle Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Lifestyle Drugs Players Market Share by Revenue
2.5.3 Global Lifestyle Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lifestyle Drugs Retrospective Market Scenario by Region
3.1 Global Lifestyle Drugs Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Lifestyle Drugs Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Lifestyle Drugs Market Facts & Figures by Country
3.3.1 North America Lifestyle Drugs Sales by Country
3.3.2 North America Lifestyle Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Lifestyle Drugs Market Facts & Figures by Country
3.4.1 Europe Lifestyle Drugs Sales by Country
3.4.2 Europe Lifestyle Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Lifestyle Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Lifestyle Drugs Sales by Region
3.5.2 Asia Pacific Lifestyle Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Lifestyle Drugs Market Facts & Figures by Country
3.6.1 Latin America Lifestyle Drugs Sales by Country
3.6.2 Latin America Lifestyle Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Lifestyle Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Lifestyle Drugs Sales by Country
3.7.2 Middle East and Africa Lifestyle Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Lifestyle Drugs Historic Market Analysis by Type
4.1 Global Lifestyle Drugs Sales Market Share by Type (2018-2023)
4.2 Global Lifestyle Drugs Revenue Market Share by Type (2018-2023)
4.3 Global Lifestyle Drugs Price by Type (2018-2023)
5 Global Lifestyle Drugs Historic Market Analysis by Sales Channel
5.1 Global Lifestyle Drugs Sales Market Share by Sales Channel (2018-2023)
5.2 Global Lifestyle Drugs Revenue Market Share by Sales Channel (2018-2023)
5.3 Global Lifestyle Drugs Price by Sales Channel (2018-2023)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Allergan Lifestyle Drugs Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly Lifestyle Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Lifestyle Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Lifestyle Drugs Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Lifestyle Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Sun Pharmacetuicals
6.6.1 Sun Pharmacetuicals Corporation Information
6.6.2 Sun Pharmacetuicals Description and Business Overview
6.6.3 Sun Pharmacetuicals Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sun Pharmacetuicals Lifestyle Drugs Product Portfolio
6.6.5 Sun Pharmacetuicals Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Lifestyle Drugs Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Forendo Pharma
6.8.1 Forendo Pharma Corporation Information
6.8.2 Forendo Pharma Description and Business Overview
6.8.3 Forendo Pharma Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Forendo Pharma Lifestyle Drugs Product Portfolio
6.8.5 Forendo Pharma Recent Developments/Updates
6.9 Avolynt
6.9.1 Avolynt Corporation Information
6.9.2 Avolynt Description and Business Overview
6.9.3 Avolynt Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Avolynt Lifestyle Drugs Product Portfolio
6.9.5 Avolynt Recent Developments/Updates
6.10 Alkermes
6.10.1 Alkermes Corporation Information
6.10.2 Alkermes Description and Business Overview
6.10.3 Alkermes Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Alkermes Lifestyle Drugs Product Portfolio
6.10.5 Alkermes Recent Developments/Updates
6.11 Dong-A ST
6.11.1 Dong-A ST Corporation Information
6.11.2 Dong-A ST Lifestyle Drugs Description and Business Overview
6.11.3 Dong-A ST Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Dong-A ST Lifestyle Drugs Product Portfolio
6.11.5 Dong-A ST Recent Developments/Updates
6.12 Dermira
6.12.1 Dermira Corporation Information
6.12.2 Dermira Lifestyle Drugs Description and Business Overview
6.12.3 Dermira Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Dermira Lifestyle Drugs Product Portfolio
6.12.5 Dermira Recent Developments/Updates
6.13 Avanir Pharmaceuticals
6.13.1 Avanir Pharmaceuticals Corporation Information
6.13.2 Avanir Pharmaceuticals Lifestyle Drugs Description and Business Overview
6.13.3 Avanir Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Avanir Pharmaceuticals Lifestyle Drugs Product Portfolio
6.13.5 Avanir Pharmaceuticals Recent Developments/Updates
6.14 Menlo Therapeutics
6.14.1 Menlo Therapeutics Corporation Information
6.14.2 Menlo Therapeutics Lifestyle Drugs Description and Business Overview
6.14.3 Menlo Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Menlo Therapeutics Lifestyle Drugs Product Portfolio
6.14.5 Menlo Therapeutics Recent Developments/Updates
6.15 Galderma
6.15.1 Galderma Corporation Information
6.15.2 Galderma Lifestyle Drugs Description and Business Overview
6.15.3 Galderma Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Galderma Lifestyle Drugs Product Portfolio
6.15.5 Galderma Recent Developments/Updates
6.16 Cerecor
6.16.1 Cerecor Corporation Information
6.16.2 Cerecor Lifestyle Drugs Description and Business Overview
6.16.3 Cerecor Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Cerecor Lifestyle Drugs Product Portfolio
6.16.5 Cerecor Recent Developments/Updates
6.17 Corcept Therapeutics
6.17.1 Corcept Therapeutics Corporation Information
6.17.2 Corcept Therapeutics Lifestyle Drugs Description and Business Overview
6.17.3 Corcept Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Corcept Therapeutics Lifestyle Drugs Product Portfolio
6.17.5 Corcept Therapeutics Recent Developments/Updates
6.18 Anterios
6.18.1 Anterios Corporation Information
6.18.2 Anterios Lifestyle Drugs Description and Business Overview
6.18.3 Anterios Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Anterios Lifestyle Drugs Product Portfolio
6.18.5 Anterios Recent Developments/Updates
6.19 Euthymics Bioscience
6.19.1 Euthymics Bioscience Corporation Information
6.19.2 Euthymics Bioscience Lifestyle Drugs Description and Business Overview
6.19.3 Euthymics Bioscience Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Euthymics Bioscience Lifestyle Drugs Product Portfolio
6.19.5 Euthymics Bioscience Recent Developments/Updates
6.20 Cosmo Pharmaceuticals
6.20.1 Cosmo Pharmaceuticals Corporation Information
6.20.2 Cosmo Pharmaceuticals Lifestyle Drugs Description and Business Overview
6.20.3 Cosmo Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Cosmo Pharmaceuticals Lifestyle Drugs Product Portfolio
6.20.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.21 AndroScience
6.21.1 AndroScience Corporation Information
6.21.2 AndroScience Lifestyle Drugs Description and Business Overview
6.21.3 AndroScience Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.21.4 AndroScience Lifestyle Drugs Product Portfolio
6.21.5 AndroScience Recent Developments/Updates
6.22 Acerus Pharmaceuticals
6.22.1 Acerus Pharmaceuticals Corporation Information
6.22.2 Acerus Pharmaceuticals Lifestyle Drugs Description and Business Overview
6.22.3 Acerus Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Acerus Pharmaceuticals Lifestyle Drugs Product Portfolio
6.22.5 Acerus Pharmaceuticals Recent Developments/Updates
6.23 Celtaxsys
6.23.1 Celtaxsys Corporation Information
6.23.2 Celtaxsys Lifestyle Drugs Description and Business Overview
6.23.3 Celtaxsys Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Celtaxsys Lifestyle Drugs Product Portfolio
6.23.5 Celtaxsys Recent Developments/Updates
6.24 Futura Medical Developments
6.24.1 Futura Medical Developments Corporation Information
6.24.2 Futura Medical Developments Lifestyle Drugs Description and Business Overview
6.24.3 Futura Medical Developments Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Futura Medical Developments Lifestyle Drugs Product Portfolio
6.24.5 Futura Medical Developments Recent Developments/Updates
6.25 Follicum
6.25.1 Follicum Corporation Information
6.25.2 Follicum Lifestyle Drugs Description and Business Overview
6.25.3 Follicum Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Follicum Lifestyle Drugs Product Portfolio
6.25.5 Follicum Recent Developments/Updates
7 Lifestyle Drugs Manufacturing Cost Analysis
7.1 Lifestyle Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Lifestyle Drugs
7.4 Lifestyle Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Lifestyle Drugs Distributors List
8.3 Lifestyle Drugs Customers
9 Lifestyle Drugs Market Dynamics
9.1 Lifestyle Drugs Industry Trends
9.2 Lifestyle Drugs Market Drivers
9.3 Lifestyle Drugs Market Challenges
9.4 Lifestyle Drugs Market Restraints
10 Global Market Forecast
10.1 Lifestyle Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Lifestyle Drugs by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Lifestyle Drugs by Type (2023-2030)
10.2 Lifestyle Drugs Market Estimates and Projections by Sales Channel
10.2.1 Global Forecasted Sales of Lifestyle Drugs by Sales Channel (2023-2030)
10.2.2 Global Forecasted Revenue of Lifestyle Drugs by Sales Channel (2023-2030)
10.3 Lifestyle Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Lifestyle Drugs by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Lifestyle Drugs by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer